Roblox Corp vs Viatris Inc — how do they compare? Roblox Corp trades at $44.87 (market cap $31.80B), while Viatris Inc trades at $16.45 (market cap $18.95B). The key difference: Roblox Corp is the larger of the two by market cap, and Viatris Inc pays a 2.91% dividend while Roblox Corp pays none. Which is the better fit depends on your goals.
| RBLX | VTRS | |
|---|---|---|
Market Cap | $31.80B | $18.95B |
Sector | Media | Health |
52-Week High | $141.56 | $17.86 |
52-Week Low | $35.54 | $9.49 |
Enterprise Value | $30.63B | $31.07B |
Dividend Yield | — | 2.91% |
Signals from Pluang's Aura AI — not financial advice
Roblox (RBLX) trades at $44.82, up 3.49% today, with a bullish technical signal and strong revenue growth to $4.89B in 2025, though net losses persist. Recent earnings beats and positive cash flow trends contrast with high valuation ratios and regulatory scrutiny. The stock is near its consensus price target of $45.71, with support at $43 and resistance at $46.
Outlook: Long-term growth potential via user engagement and creator economy is tempered by profitability challenges and child-safety regulations. Risks include sustained losses and competitive pressure, but analyst sentiment leans slightly bullish with 44.74% buy ratings. Investors should weigh revenue momentum against margin improvement needs.
Viatris (VTRS) trades at $16.61, down 1.6% on the day, with a bullish technical signal but mixed moving averages. The company reported Q2 2026 EPS of $0.69, beating estimates, and revenue growth of 5% year-over-year. Despite negative net income margins, strong cash flow generation supports dividends and buybacks. Recent news highlights pipeline progress and a higher 2026 outlook.
Outlook: Viatris shows operational strength with consistent earnings beats and cash flow, but high P/E and negative profitability pose risks. Investment opportunity lies in deleveraging and pipeline advancements, while headwinds include generic drug pricing pressure and regulatory uncertainty. Analyst sentiment is mixed with a hold-heavy consensus.
Trailing returns across standard periods
Latest headlines on both assets
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →